DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Targeting Splicing in the Treatment of Human Disease
The tightly regulated process of precursor messenger RNA (pre-mRNA) alternative splicing (AS) is a key mechanism in the regulation of gene expression. Defects in this regulatory process affect cellular functions and are the cause of many human diseases. Recent advances in our understanding of splicing regulation have led to the development of new tools for manipulating splicing for therapeutic purposes. Several tools, including antisense oligonucleotides and <i>trans</i>-splicing, have been developed to target and alter splicing to correct misregulated gene expression or to modulate transcript isoform levels. At present, deregulated AS is recognized as an important area for therapeutic intervention. Here, we summarize the major hallmarks of the splicing process, the clinical implications that arise from alterations in this process, and the current tools that can be used to deliver, target, and correct deficiencies of this key pre-mRNA processing event., This work was supported by grants from the Spanish Ministry of Economy and
Competitiveness (grant number BFU2014-54660-R) and the Andalusian Government (Excellence Project
BIO-2515/2012) to Carlos Suñé and from the Spanish Ministry of Economy and Competitiveness (grant number
BFU2016-79699-P) and the Andalusian Government (Excellence Project CTS-6587) to Cristina Hernández-Munain
Support from the European Region Development Fund (ERDF (FEDER)) is also acknowledged. We apologize to
all researchers whose papers pertinent to this article we failed to cite, We acknowledge support by the CSIC Open Access Publication Initiative through its Unit of Information Resources for Research (URICI).